B
Babson Diagnostics
Medical technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter
About Babson Diagnostics
Babson Diagnostics is a healthcare technology company focused on revolutionizing the diagnostic blood testing experience. The company aims to make routine blood testing less invasive and more convenient by using a small amount of blood collected from a finger prick. This approach ensures medically accurate results while prioritizing patient comfort and accessibility. Babson Diagnostics primarily serves patients who require regular blood tests, healthcare providers, and local pharmacies. Operating in the healthcare diagnostics market, the company employs a business model that integrates its technology into local pharmacies, making blood testing more accessible to the general public. Revenue is generated through partnerships with pharmacies and healthcare providers, as well as direct payments from patients for testing services. Babson Diagnostics leverages its science-first approach to ensure high-quality, reliable results, positioning itself as a leader in the healthcare technology space.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Austin, United States
- Employees
- 53
- Open positions
- None listed
- Dealroom signal
- 34.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Oct 2024 | $0 | — | BD | ↗ |
| SERIES B✓Equity / VC | Jun 2021 | $31M | $124M | Prizm Ventures · Emerald Development Managers · Siemens Healthineers · Lago Consulting | — |
Growth signals
Latest recorded traffic for Babson Diagnostics is 15K monthly website visits, up 36.4% over the last three months. Babson Diagnostics's team declined 7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- PMPrism Venture Management
- GCGenesis Merchant Capital
Lago Consulting
Siemens Healthineers
Emerald Development Managers
Prizm Ventures
Series B and later1 investor entered at this stage
BD
Other known investors1 additional known investor
Rainer Schwarz
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Babson Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Babson Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.